SAS and Carolina partner to accelerate antiviral drug development

Posted Nov 19, 2021
SAS, a leader in analytics and software services, and the University of North Carolina are teaming up to transform the drug development process to prevent infectious disease threats from turning into a pandemic like COVID-19. The partnership is focused on the work of the University’s Rapidly Emerging Antiviral Drug Development Initiative (READDI). (UNC.edu)

Related: Campus Connections

North Carolina Icons: Andy Griffith
After graduating from the University of North Carolina, performing in seven seasons of The Lost Colony in Manteo, and teaching music and drama at Goldsboro...
Thu Jan 1, 2026

Carolina Insider Podcast: UNC Basketball vs. Florida State Preview, Larry Keith Joins
North Carolina Men's Basketball wrapped up non-conference play just before the holiday break (8:10) and begins ACC play against Florida State in the Smith Center...
Tue Dec 30, 2025

Stuart Scott’s 30 for 30 brought back a lot of hard memories
I never met Stuart Scott. I really wish I had. He hit ESPN at just the right time. I had just started high school when...
Sun Dec 28, 2025

Odd happenings on UNC’s campus in 2025
Tyler Hansbrough, a star UNC basketball player from 2005 to 2009, made a surprising resurgence in Carolina culture this year. Hansbrough co-taught a sports communication...
Sun Dec 28, 2025